TY - JOUR
T1 - TSLP-REGULATED GENE EXPRESSION SIGNATURE IN A PRECLINICAL MODEL OF CRLF2 B-ALL
AU - Martinez, Shannalee
AU - Francis, Olivia
AU - Su, Ruijun
AU - Baez, Ineavely
AU - Fisher, Ross
AU - Morris, Christopher
AU - Zhang, Xiaobing
AU - Filippov, Valeri
AU - Dovat, Sinisa
AU - Payne, Kimberly
N1 - Cookies are disabled for this browser. Wiley Online Library requires cookies for authentication and use of other site features; therefore, cookies must be enabled to browse the site. Detailed information on how Wiley uses cookies can be found in our Privacy Policy.
PY - 2014/5
Y1 - 2014/5
N2 - Background: Cure requires sustained treatment, but, failure to complete indicated treatment (treatment abandonment) occurs in up to one quarter of pediatric tuberculosis cases and half of pediatric oncology cases in some low- and middleincome settings (LMIS). Objectives: This systematic review assesses the design, delivery and outcomes of adherence interventions utilized in pediatric tuberculosis in LMIS, and evaluates the potential application of these interventions for pediatric oncology treatment adherence. Design/Method: A protocol was drafted in alignment with PRISMA standards and registered with PROSPERO. 412 reports published between 2003 and 2013 were identified from PubMed, COCHRANE bibliographies, hand-searching including of the grey literature, and expert consultation. 163 reports qualified for full-text review. Randomized control, quasi-experimental, and observational studies that utilized an intervention specific to treatment completion, adherence, prevention of refusal, or family-efficacy with a reported adherence-related outcome for pediatric-age populations (
AB - Background: Cure requires sustained treatment, but, failure to complete indicated treatment (treatment abandonment) occurs in up to one quarter of pediatric tuberculosis cases and half of pediatric oncology cases in some low- and middleincome settings (LMIS). Objectives: This systematic review assesses the design, delivery and outcomes of adherence interventions utilized in pediatric tuberculosis in LMIS, and evaluates the potential application of these interventions for pediatric oncology treatment adherence. Design/Method: A protocol was drafted in alignment with PRISMA standards and registered with PROSPERO. 412 reports published between 2003 and 2013 were identified from PubMed, COCHRANE bibliographies, hand-searching including of the grey literature, and expert consultation. 163 reports qualified for full-text review. Randomized control, quasi-experimental, and observational studies that utilized an intervention specific to treatment completion, adherence, prevention of refusal, or family-efficacy with a reported adherence-related outcome for pediatric-age populations (
UR - https://onlinelibrary.wiley.com/doi/epdf/10.1002/pbc.25032
UR - https://www.mendeley.com/catalogue/2c0d792e-ef9b-30f1-8e3a-2210d40c7725/
U2 - 10.1002/pbc.25032
DO - 10.1002/pbc.25032
M3 - Meeting abstract
VL - 61
JO - Pediatric Blood Cancer
JF - Pediatric Blood Cancer
IS - S1
ER -